Merck & Company, Inc. (MRK)
Latest news, insights and market data
Market Data
$117.10
$1.97 (-1.65%)
Previous Close: $119.07
52-Week Range
35% from low
$112.72$125.14
AI Insights
No news
Updated about 21 hours ago
Latest News
| Title | Published |
|---|---|
Merck Wins EU Approval for ENFLONSIA to Protect Infants from RSV Merck Wins EU Approval for ENFLONSIA to Protect Infants from RSV | about 6 hours ago |
Merck (MRK) Sees a More Significant Dip Than Broader Market: Some Facts to Know Merck (MRK) Sees a More Significant Dip Than Broader Market: Some Facts to Know | about 9 hours ago |
3 Reasons We Love Merck (MRK) 3 Reasons We Love Merck (MRK) | about 10 hours ago |
Can BMY's Growth Portfolio Counter Legacy Drugs Decline in Q1? Can BMY's Growth Portfolio Counter Legacy Drugs Decline in Q1? | about 13 hours ago |
Has The 58% One Year Surge In Merck (MRK) Gone Too Far On Valuation? Has The 58% One Year Surge In Merck (MRK) Gone Too Far On Valuation? | about 14 hours ago |
Merck Secures EU Nod for RSV Antibody Enflonsia in Infants Merck Secures EU Nod for RSV Antibody Enflonsia in Infants | about 18 hours ago |
Will AbbVie's Oncology Franchise Weigh on Q1 Top-line Growth? Will AbbVie's Oncology Franchise Weigh on Q1 Top-line Growth? | about 19 hours ago |
Merck Wins EU Approval for ENFLONSIA to Protect Infants from RSV
Merck Wins EU Approval for ENFLONSIA to Protect Infants from RSV
about 6 hours ago
Merck (MRK) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Merck (MRK) Sees a More Significant Dip Than Broader Market: Some Facts to Know
about 9 hours ago
3 Reasons We Love Merck (MRK)
3 Reasons We Love Merck (MRK)
about 10 hours ago
Can BMY's Growth Portfolio Counter Legacy Drugs Decline in Q1?
Can BMY's Growth Portfolio Counter Legacy Drugs Decline in Q1?
about 13 hours ago
Has The 58% One Year Surge In Merck (MRK) Gone Too Far On Valuation?
Has The 58% One Year Surge In Merck (MRK) Gone Too Far On Valuation?
about 14 hours ago
Merck Secures EU Nod for RSV Antibody Enflonsia in Infants
Merck Secures EU Nod for RSV Antibody Enflonsia in Infants
about 18 hours ago
Will AbbVie's Oncology Franchise Weigh on Q1 Top-line Growth?
Will AbbVie's Oncology Franchise Weigh on Q1 Top-line Growth?
about 19 hours ago